JR Biomedical Ltd has an active R&D program for the development of new rapid diagnostics for both clinical and self test use.
A pipeline of new SELFCheck products will be registered and released for sale during 2019-2020, doubling the number of products available. A new point of care test for the early diagnosis of sepsis is under development with a UK university and will be launched for clinical use in Q4, 2019.
We are keen to collaborate with universities and pharmaceutical companies for the development of new in-vitro diagnostics.
Regular announcements regarding the progress of our research and development is posted on social media.